Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02410135 · ClinicalTrials.gov registry record
Myrbetriq™ (Mirabegron) to Improve Disordered Sleep in Subjects With Lower Urinary Tract Symptoms (LUTS)
A clinical trial, sponsored by Southern Illinois University.
- Completed
- Registry status
- 34
- Enrollment target
NCT02410135 is a clinical trial that has completed, run by Southern Illinois University. The registered enrollment target is 34 participants.
The verdict
NCT02410135 has completed, sponsored by Southern Illinois University.
- COMPLETED
- Registry status
- 34 participants
- Enrollment target
Study Summary
The objective of this exploratory pilot study is to assess whether Mirabegron (Myrbetriq™) will improve the quality of sleep and Lower Urinary Tract Symptoms (LUTS) in men and women presenting with LUTS and disordered sleep.
Interventions
- DRUG Mirabegron
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2015-04 |
| Est. Completion | 2018-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02410135
The ClinicalTrials.gov registry entry for NCT02410135 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Southern Illinois University, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Mirabegron is the first listed.
NCT02410135 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02410135 about?
NCT02410135 is a clinical study titled "Myrbetriq™ (Mirabegron) to Improve Disordered Sleep in Subjects With Lower Urinary Tract Symptoms (LUTS)". The objective of this exploratory pilot study is to assess whether Mirabegron (Myrbetriq™) will improve the quality of sleep and Lower Urinary Tract Symptoms (LUTS) in men and women presenting with LUTS and disordered sleep.
What is the current status of trial NCT02410135?
This trial is currently completed. The enrollment target is 34 participants. The study started on 2015-04. Estimated completion is 2018-12.
What interventions are being tested in trial NCT02410135?
The interventions under investigation include: Mirabegron (DRUG).
Who is sponsoring clinical trial NCT02410135?
This trial is sponsored by Southern Illinois University, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.